ArticleExperimental and therapeutic medicine2025
A
Article in Experimental and therapeutic medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In children aged 3 months to 6 years, convulsions that occur when the body temperature reaches >38˚C are referred to as febrile seizures (FS), provided that central nervous system infections and other metabolic etiologies are excluded. Generalized epilepsy with FS plus (GEFS+) refers to children who continue to suffer from FS after the age of 6 years with or without generalized and partial epileptic seizures. It is characterized by incomplete penetrance and genetic heterogeneity. In recent years, genetic techniques have undergone advancements, such that multiple genes can now be identified in clinical screenings, providing assistance in the diagnosis and delineation of diseases. Evidence suggests that mutations in a protein coding gene, γ-aminobutyric acid type A receptor β3 subunit (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.